Case number: 1:25-bk-15637 - Noble Life Sciences, Inc. - Maryland Bankruptcy Court

Case Information
  • Case title

    Noble Life Sciences, Inc.

  • Court

    Maryland (mdbke)

  • Chapter

    11

  • Judge

    Michelle M. Harner

  • Filed

    06/22/2025

  • Last Filing

    03/03/2026

  • Asset

    Yes

  • Vol

    v

Docket Header
PlnDue, EXHIBITS, APFee



U.S. Bankruptcy Court
District of Maryland (Baltimore)
Bankruptcy Petition #: 25-15637

Assigned to: Judge Michelle M. Harner
Chapter 11
Voluntary
Asset


Date filed:  06/22/2025
341 meeting:  07/23/2025
Deadline for filing claims:  10/21/2025
Deadline for filing claims (govt.):  12/19/2025
  
Case Administrator:   Kelly Horning
Team 2 Phone:    301-344-3965

Debtor

Noble Life Sciences, Inc.

1500 Fannie Dorsey Road
Sykesville, MD 21784
CARROLL-MD
Tax ID / EIN: 27-2336482

represented by
Robert B. Scarlett

Scarlett & Croll, P.A.
306 W. Chesapeake Ave.
Baltimore, MD 21204
410-468-3100
Fax : 410-332-4026
Email: RScarlett@ScarlettCroll.com

Trustee

For Internal Use Only

Email: bnc@mdb.uscourts.gov

 
 
U.S. Trustee

US Trustee - Baltimore

Garmatz Federal Courthouse
101 West Lombard Street
Suite 2625
Baltimore, MD 21201
(410) 962-4300
Fax : (410) 962-3537
Email: USTPRegion04.BA.ECF@USDOJ.GOV
represented by
Hugh M. (UST) Bernstein

Office of U.S. Trustee
101 W. Lombard Street
Suite 2625
Baltimore, MD 21201
(410) 962-7771
Email: hugh.m.bernstein@usdoj.gov

Omnia Shedid

DOJ-Ust
101 West Lombard Street
Suite 2625
Baltimore, MD 21201
410-962-4300
TERMINATED: 08/13/2025

Latest Dockets

Date Filed#Docket Text
03/03/2026255Certificate of Service of electronic and First Class Mailing of Redline Copies of Debtor's Amended Plan and Disclosure Statement Filed by Robert B. Scarlett (related document(s)[253] Line filed by Debtor Noble Life Sciences, Inc., [254] Line filed by Debtor Noble Life Sciences, Inc.). (Attachments: # (1) Exhibit 1 - Cover Letter) (Scarlett, Robert)
03/03/2026254Line Redline and Comparison Copy of Debtor's Amended Disclosure Statement on behalf of Noble Life Sciences, Inc. Filed by Robert B. Scarlett (related document(s)[244] Amended Disclosure Statement filed by Debtor Noble Life Sciences, Inc.). (Scarlett, Robert)
03/03/2026253Line Redline and Comparison Copy of Debtor's Amended Chapter 11 Plan to Original Plan on behalf of Noble Life Sciences, Inc. Filed by Robert B. Scarlett (related document(s)[243] Amended Chapter 11 Plan filed by Debtor Noble Life Sciences, Inc.). (Scarlett, Robert)
03/03/2026252Motion For Late Filing Of Red-Line Copy Of Debtors Amended Plan And Debtors Amended Disclosure Statement Filed by Noble Life Sciences, Inc.. (Attachments: # (1) Proposed Order on late filing) (Scarlett, Robert)Modified on 3/4/2026 enhanced title ot text(Horning, Kelly).
03/03/2026251Withdrawal of Document on behalf of Noble Life Sciences, Inc. Filed by Robert B. Scarlett (related document(s)[249] Exhibit/Witness List filed by Debtor Noble Life Sciences, Inc.). (Scarlett, Robert)
03/03/2026250Debtors Witness List, And Exhibits For Disclosure Statement Hearing On March 12, 2026 Filed by Robert B. Scarlett. (Attachments: # (1) Exhibit P01 - Resume of Alain Cappeluti # (2) Exhibit P02 - Lease Modification Agreement # (3) Exhibit PO 3 - Strategic Plan) (Scarlett, Robert)Modified on 3/4/2026 enhanced title of text(Horning, Kelly).
03/03/2026249*WITHDRAWN AT [251]*Exhibit/Witness List Filed by Robert B. Scarlett. (Attachments: # (1) Exhibit PO1 - Resume of Alain Cappeluti # (2) Exhibit 2 - Exhibit PO2 - Supplemental Lease # (3) Exhibit PO3 - Strategic Plan) (Scarlett, Robert)Modified on 3/4/2026 (Horning, Kelly).
02/25/2026248BNC Certificate of Mailing - PDF Document. (related document(s)[246] Order on Motion to Use Cash Collateral). No. of Notices: 1. Notice Date 02/25/2026. (Admin.)
02/24/2026247Chapter 11 Monthly Operating Report for the Month Ending: 01/31/2026 Filed by Robert B. Scarlett. (Attachments: # (1) Exhibit 1 - Exhibit B # (2) Exhibit 2 - Profit and Loss Statement # (3) Exhibit 3 - Balance Statement # (4) Exhibit 4 - Statement of Cash Flows # (5) Exhibit 5 - Shore Bank Reconciliation # (6) Exhibit 6 - Accounts Receivables # (7) Exhibit 7 - Accounts Receivable Aging # (8) Exhibit 8 - January Shore Bank Statement # (9) Exhibit 9 - Amazon Credit Card Statement # (10) Exhibit 10 - SouthWest Credit Card Statement # (11) Exhibit 11 - Citi Bank Credit Card Statement # (12) Exhibit 12 - Credit Card Summary # (13) Exhibit 12 - Credit Card Summary # (14) Exhibit 14 - Quickbooks Payroll report # (15) Exhibit 15 - Transactions Report January # (16) Certificate of Service) (Scarlett, Robert)
02/23/2026246Fifth Consent Order Approving Debtors Interim Use Of Cash Collateral (related document(s):[12] Emergency Motion to Use Cash Collateral and Payment of Pre-Petition Wages filed by Debtor Noble Life Sciences, Inc.). A continued hearing on the Debtors use of cash collateral will be held on April 27, 2026, at 11:00 a.m., in person in Courtroom 9-C, Baltimore Judge Harner. (Horning, Kelly) Modified on 2/24/2026 to add hearing information. (Komisarek, Anna Marie).